ESMO IOTECH

137 posts

ESMO IOTECH

@esmo_iotech

IOTECH publishes pre-clinical & clinical studies covering natural & therapy-induced innate & adaptive immune responses against solid/haematological cancers

Katılım Eylül 2021

157 Takip Edilen356 Takipçiler

Sabitlenmiş Tweet

ESMO IOTECH@esmo_iotech·14 Eyl

IOTECH is the newest @myESMO #OpenAccess journal. We aim to publish the highest quality #immunooncology research and aspire to provide a forum for leaders in the IO field. Led by EIC @HaanenJohn, we look forward to receiving your research manuscripts. youtu.be/WxTr1pyBGjE

YouTube

English

ESMO IOTECH retweetledi

ESMO - Eur. Oncology@myESMO·11 Ara

The impact of #GutMicrobiota on #immunotherapy response and resistance has been established, but studies presented at #ESMOImmuno24 highlight important associations between microbiota and immunotherapy-related toxicities.  #ESMODailyReporter 📌ow.ly/SPtC50Up9u8

English

1.7K

ESMO IOTECH retweetledi

ESMO - Eur. Oncology@myESMO·11 Ara

#ESMOImmuno24: According to the 2024 ESMO Immuno-Oncology Awardee, @Schumacher_lab, tackling the T-cell receptor challenge w/ vast datasets and cutting-edge high-throughput methods may pave the way for advances in #immunotherapy. #ESMODailyReporter 📌ow.ly/rZUO50Up0BE

English

1.7K

ESMO IOTECH@esmo_iotech·11 Ara

It's finally here! #ESMOImmuno24 📚 Delighted that all accepted abstracts, including late-breaking abstracts, will be published online in the 'ESMO Immuno-Oncology Congress 2024 Abstract Book', a supplement to @esmo_iotech.

ESMO - Eur. Oncology@myESMO

📣 #ESMOImmuno24: J. Haanen, J. Naidoo, K. Harrington and A. di Giacomo highlight the benefits of sharing your research at this event. ⏰ Deadline: 1 October 📅 Dates: 11-13 December 2024 📍 Location: Geneva, Switzerland 🔗 Submit your abstract: ow.ly/YPwS50T1Yok

English

264

ESMO IOTECH retweetledi

ESMO - Eur. Oncology@myESMO·5 Kas

.@Schumacher_lab was bestowed the 2024 ESMO Award for Immuno-Oncology. He will deliver his award lecture on Wednesday, 11 December 2024 at the opening session of #ESMOImmuno24. 📌ow.ly/FiiN50U0iab

English

ESMO IOTECH retweetledi

ESMO - Eur. Oncology@myESMO·11 Ara

#ESMOImmuno24: Real-world evidence has a place in #CancerImmunotherapy. However, some challenges still limit its implementation in #ClinicalPractice. #ESMODailyReporter #ESMO-GROW @DoniaMarco 📌ow.ly/rwXC50UoUCo

English

1.6K

ESMO IOTECH@esmo_iotech·11 Ara

Welcome to Geneva 🇨🇭 for the much awaited #ESMOImmuno24! 💡 Presenting your work at #ESMOImmuno24? Looking for a home for your research work? Consider submitting to @esmo_iotech: 🔗 esmoiotech.org

English

282

ESMO IOTECH@esmo_iotech·5 Kas

📢 Check out this original article by Konïg & colleagues @UniBasel_en @UniSpitalBasel 🇨🇭. 💉 BaseTIL trial: A single-center investigator-initiated phase I study of TILs + nivolumab in patients with advanced melanoma. Available #OpenAccess 👇 esmoiotech.org/article/S2590-…

English

667

ESMO IOTECH@esmo_iotech·5 Kas

📢 Check out this special case report by Monberg, Svane & colleagues @CCITdk @helsinkiuni @Rigshospitalet 🇩🇰🇫🇮. 💉Combined treatment with TILs + oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma. Available #OpenAccess 👇esmoiotech.org/article/S2590-…

English

483

ESMO IOTECH@esmo_iotech·25 Eki

📢 Check out this latest original article by @TGruijl & team @amsterdamumc. 🧫An organotypic human melanoma-in-skin model as an in vitro tool for testing Vγ9Vδ2-T cell-based immunotherapy. Available #OpenAccess 👇 esmoiotech.org/article/S2590-…

English

ESMO IOTECH@esmo_iotech·25 Eki

📢 Check out this latest original article by Yeghaian, @S_Trebeschi + colleagues 🇳🇱🇨🇭🇩🇰. 🔬 Integrated noninvasive dx for prediction of survival in immunotherapy: Longitudinal CT, blood tests & clinical parameters ▶️ AI models. Available #OpenAccess 👇 esmoiotech.org/article/S2590-…

English

ESMO IOTECH@esmo_iotech·11 Eki

📢 Hear first hand from our Editor-in-Chief Prof @HaanenJohn about ESMO IOTECH - @myESMO’s peer-reviewed open-access specialised journal dedicated to publishing advances in immuno-oncology and technology 👇

English

3.3K

ESMO IOTECH@esmo_iotech·12 Eyl

💡 Presenting your work at #ESMO24 in Barcelona 🇪🇸? Looking for a home for your research work? Consider submitting to @esmo_iotech 👇 🔗 esmoiotech.org

English

433

ESMO IOTECH retweetledi

ESMO - Eur. Oncology@myESMO·6 Eyl

#ESMO24: Do not miss the latest #CancerResearch brought to you by the #ESMOAmbassadors & become part of the conversation. 📌 ow.ly/PgWM50Th6Q3

English

102

84.2K

ESMO IOTECH@esmo_iotech·29 Ağu

📢 Check out this latest original article by van Duin & colleagues - a multicentre study 🇳🇱. 🔬 Investigating association between TIL abundance in pre-tx primary/metastasis & development of severe irAEs in advanced melanoma. Available #OpenAccess 👇 esmoiotech.org/article/S2590-…

English

247

ESMO IOTECH@esmo_iotech·13 Ağu

🔖 Latest REVIEW by Olivera & @DrIgMelero + colleagues on 'Regional and intratumoral adoptive T-cell therapy'. Available #OpenAccess 👇 esmoiotech.org/article/S2590-…

English

304

ESMO IOTECH@esmo_iotech·9 Ağu

Congratulations to our ESMO IOTECH's Editor-in-Chief @HaanenJohn for the 2024 ESMO Lifetime Achievement Award 🏅. Well-deserved distinction, and we are all so delighted! #ESMO24 @myESMO

ESMO - Eur. Oncology@myESMO

#ESMO24: ESMO has announced the recipients of the 2024 ESMO Society Awards in recognition of their work in strengthening the oncology field and supporting fellow oncologists in their professional careers. 📌ow.ly/Kopk50SRQUk

English

237

ESMO IOTECH@esmo_iotech·17 Haz

📚 There's still time to submit your work to this ESMO IOTECH Special Issue on 'Developments in Cell Therapy', with guest editors: @alena_grosvidal & @sklobuch. For further details, please check out: spkl.io/60164sUYj

ESMO IOTECH@esmo_iotech

🚨 SPECIAL ISSUE: Developments in Cell Therapy 🚨 ⏰ Submit an original article/review by 1 July 2024 📈 2022 CiteScore: 5.5 🔖 Indexed on PMC & PubMed @NLM_NIH: 'Immunooncol Technol' Further details: spkl.io/60164sUYj Guest editors: @alena_grosvidal & @sklobuch

English

694

ESMO IOTECH@esmo_iotech·7 Haz

📢 Check out this latest original article by @CostaSvedman & colleagues @KarolinskaUnsju @KarolinskaInst. 🏥 Effect of glucocorticoids for the management of irAEs on outcome in IO-treated melanoma patients. Available #OpenAccess👇 esmoiotech.org/article/S2590-…

English

ESMO IOTECH@esmo_iotech·31 May

📑 Presenting your work at #ASCO24 in Chicago 🇺🇸? Looking for a home for your research work? Consider submitting to @esmo_iotech 👇 esmoiotech.org

English

185

ESMO IOTECH retweetledi

ESMO IOTECH@esmo_iotech·14 Ara

IOTECH aspires to provide a forum for today's leaders in the field of #ImmunoOncology. We welcome: ➡️pre-clinical/clinical studies ➡️solid/haematological cancers ➡️technological advances that decipher & improve clinical outcomes Get in touch today!

English

1.8K

Keşfet

@Schumacher_lab @DoniaMarco @UniBasel_en @UniSpitalBasel @CCITdk @helsinkiuni @Rigshospitalet @TGruijl